
NKTR
Delayed Nasdaq - 04/23 10:00:00 pm
85.45USD
-0.88%
Prev. | 86.2100 |
Open | 86.8000 |
High | 86.8800 |
Low | 82.1100 |
Volume | 2 860 138 |
Last news
Financials
|
|
Company
Nektar Therapeutics is a clinical-stage biopharmaceutical company, which engages in developing drug candidates that utilize its PEGylation and polymer conjugate technology platforms.Its products contain drug candidates of therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and...
Sector : |
Biotechnology & Medical Research - NEC
|
Calendar : |
2018-04-28 Presentation
|
Trading Rating : |
Investor Rating : |
Technical analysis trends
Short Term | Mid-Term | Long Term | |
Trend | Bearish | Bullish | Bullish |
Resistance | 93,9 | 108 | 108 |
Spread/Res. | -9,0% | -21% | -21% |
Spread/Supp. | 0,62% | 49% | 99% |
Support | 84,9 | 57,4 | 43,0 |